Files
Download Full Text (1.4 MB)
Download VTE risk assessment Algorithm (156 KB)
Download COVID-19 VTE prophylaxis (160 KB)
Download Standard heparin Algorithm (247 KB)
Download Low molecular weight heparin Algorithm (247 KB)
Download Warfarin therapy Algorithm (314 KB)
Download Rivaroxaban Algorithm (266 KB)
Download Bivalirudin Algorithm (200 KB)
Publication Date
11-2023
Disclaimer
These guidelines do not establish a standard of care to be followed in every case. It is recognized that each case is different and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare guidelines for each. Accordingly, these guidelines should guide care with the understanding that departures from them may be required at times.
Objective of the Clinical Pathway
To provide care standards for patients requiring anticoagulation therapy for treatment or prophylaxis. The Anticoagulation Therapies & VTE Risk Assessment Clinical Pathways provide guidance regarding initiation of therapy and ongoing management to enhance patient safety and minimize variation of care.
Target Users
Physicians (Hospital Medicine, Fellows, Residents); Nurse Practitioners; Nurses; Pharmacy
Disciplines
Pediatrics
Recommended Citation
Children's Mercy Kansas City, "Anticoagulation Therapies and VTE Risk Assessment" (2023). Clinical Pathways.
https://scholarlyexchange.childrensmercy.org/clinical_pathways/4
Comments
Finalized: 2016; Revised 7/2018; 10/2019; 2/2022; 9/2023; 11/2023
Clinical Pathways are updated on a revision schedule. Primary files will always be the most current update. Previous revisions are available upon request from Children’s Mercy Library Services.